|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 8/14/20 Creative Medical Tech Holdin… Inc 10-Q 6/30/20 43:2M Discount Edgar/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 248K
2: EX-31.1 Certification -- §302 - SOA'02 HTML 18K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 18K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 14K
5: EX-32.2 Certification -- §906 - SOA'02 HTML 14K
12: R1 Cover HTML 47K
13: R2 Condensed Consolidated Balance Sheets HTML 74K
14: R3 Condensed Consolidated Balance Sheets HTML 38K
(Parenthetical)
15: R4 Condensed Consolidated Statement of Operations HTML 68K
(Unaudited)
16: R5 Condensed Consolidated Statements of Cash Flows HTML 77K
(Unaudited)
17: R6 Condensed Consolidated Statements of Stockholders' HTML 64K
Deficit (Unaudited)
18: R7 Organization and Summary of Significant Accounting HTML 38K
Policies
19: R8 Licensing Agreements HTML 24K
20: R9 Related Party Transactions HTML 17K
21: R10 Debt HTML 20K
22: R11 Derivative Liabilities HTML 19K
23: R12 Warrants HTML 22K
24: R13 Subsequent Events HTML 17K
25: R14 Organization and Summary of Significant Accounting HTML 57K
Policies (Policies)
26: R15 Organization and Summary of Significant Accounting HTML 31K
Policies (Tables)
27: R16 Debt (Tables) HTML 17K
28: R17 Warrants (Tables) HTML 25K
29: R18 Organization and Summary of Significant Accounting HTML 31K
Policies (Details)
30: R19 Organization and Summary of Significant Accounting HTML 33K
Policies (Details 1)
31: R20 Organization and Summary of Significant Accounting HTML 26K
Policies (Details Narrative)
32: R21 Licensing Agreements (Details Narrative) HTML 60K
33: R22 Related Party Transactions (Details) HTML 25K
34: R23 Debt (Details) HTML 20K
35: R24 Debt (Details Narrative) HTML 48K
36: R25 Derivative Liabilities (Details Narrative) HTML 45K
37: R26 Warrants (Details) HTML 28K
38: R27 Warrants (Details 1) HTML 29K
39: R28 Warrants (Details Narrative) HTML 15K
40: R29 Subsequent Events (Details Narrative) HTML 35K
42: XML IDEA XML File -- Filing Summary XML 70K
41: EXCEL IDEA Workbook of Financial Reports XLSX 44K
6: EX-101.INS XBRL Instance -- celz-20200630 XML 553K
9: EX-101.CAL XBRL Calculations -- celz-20200630_cal XML 85K
11: EX-101.DEF XBRL Definitions -- celz-20200630_def XML 306K
8: EX-101.LAB XBRL Labels -- celz-20200630_lab XML 513K
10: EX-101.PRE XBRL Presentations -- celz-20200630_pre XML 421K
7: EX-101.SCH XBRL Schema -- celz-20200630 XSD 92K
43: ZIP XBRL Zipped Folder -- 0001477932-20-004986-xbrl Zip 68K
EXHIBIT 32.2
CERTIFICATION OF
PRINCIPAL FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350
In connection with this Quarterly Report of Creative Medical Technology Holdings, Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2020, as filed with the Securities and Exchange Commission on the date hereof (the “Quarterly Report”), I, Donald Dickerson, Chief Financial Officer of the Company, certify to the best of my knowledge, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:
|
| 1. | Such Quarterly Report on Form 10-Q for the period ended June 30, 2020, fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|
| 2. | The information contained in such Quarterly Report on Form 10-Q for the period ended June 30, 2020, fairly presents, in all material respects, the financial condition and results of operations of Creative Medical Technology Holdings, Inc. |
| Date: August 14, 2020 | By: | /s/ Donald Dickerson |
|
|
|
|
| |
|
|
| Chief Financial Officer |
|
|
|
| (Principal Financial Officer) |
|
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 8/14/20 | None on these Dates | ||
| For Period end: | 6/30/20 | |||
| List all Filings | ||||